SEC Form 4 · accession 0001595262-16-000065
IMS Health Holdings, Inc. · Q
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harvey A. Ashman
Officer — See Remarks
Period of report
Oct 3, 2016
Accepted (ET)
Oct 3, 2016 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 3, 2016 | A | 3,587 | — | A | 29,086 | D | |
| Common StockF3 | Oct 3, 2016 | A | 4,478 | — | A | 33,564 | D | |
| Common StockF4 | Oct 3, 2016 | D | 33,564 | — | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $10.00 | Oct 3, 2016 | D | 80,000 | D | Feb 26, 2012 | Mar 15, 2020 | Common Stock | 80,000 | 0 | D |
| Employee Stock Option (right to buy)F6 | $5.80 | Oct 3, 2016 | D | 40,000 | D | Feb 26, 2013 | Mar 15, 2020 | Common Stock | 40,000 | 0 | D |
| Employee Stock Option (right to buy)F7 | $3.20 | Oct 3, 2016 | D | 80,000 | D | Feb 26, 2015 | Mar 15, 2020 | Common Stock | 80,000 | 0 | D |
| Employee Stock Option (right to buy)F8 | $9.80 | Oct 3, 2016 | D | 5,000 | D | May 8, 2013 | May 8, 2022 | Common Stock | 5,000 | 0 | D |
| Employee Stock Option (right to buy)F9 | $7.20 | Oct 3, 2016 | D | 15,000 | D | May 8, 2016 | May 8, 2022 | Common Stock | 15,000 | 0 | D |
| Employee Stock Option (right to buy)F10 | $7.20 | Oct 3, 2016 | D | 3,000 | D | May 8, 2017 | May 8, 2022 | Common Stock | 3,000 | 0 | D |
| Employee Stock Option (right to buy)F12,F11 | $7.20 | Oct 3, 2016 | D | 2,000 | D | May 8, 2017 | May 8, 2020 | Common Stock | 2,000 | 0 | D |
| Stock Appreciation RightF13 | $25.02 | Oct 3, 2016 | D | 2,022 | D | Feb 10, 2016 | Feb 10, 2025 | Common Stock | 2,022 | 0 | D |
| Stock Appreciation RightF15,F14 | $25.02 | Oct 3, 2016 | D | 6,068 | D | — | Feb 10, 2025 | Common Stock | 6,068 | 0 | D |
| Stock Appreciation RightF17,F16 | $23.00 | Oct 3, 2016 | D | 9,968 | D | — | Feb 2, 2026 | Common Stock | 9,968 | 0 | D |
Explanation of responses
- F1On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
- F10This option was assumed by Quintiles in the merger and replaced with an option to purchase 1,152 shares of Quintiles IMS Holdings, Inc. common stock at a price of $18.75 per share.
- F11On May 8, 2012, the reporting person was granted a performance-based option to purchase 10,000 shares of common stock. This option vests in five equal annual installments beginning May 8, 2013, subject to the achievement of certain performance criteria for each of the fiscal years ending December 31, 2012, 2013, 2014, 2015, and 2016. In connection with the merger, the performance criteria was achieved resulting in the option vesting with respect to 2,000 shares of issuer common stock. The performance-based option was assumed by Quintiles in the merger and replaced with a time-based option.
- F12This option was assumed by Quintiles in the merger and replaced with an option to purchase 768 shares of Quintiles IMS Holdings, Inc. common stock at a price of $18.75 per share.
- F13This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 776 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
- F14This stock appreciation right vests in three annual installments beginning on February 10, 2017.
- F15This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 2,330 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
- F16This stock appreciation right vests in four annual installments beginning on February 2, 2017.
- F17This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 3,827 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share.
- F2On February 10, 2015, the reporting person was granted 3,010 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 3,587 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 1,377 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017.
- F3On February 2, 2016, the reporting person was granted 3,252 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 4,478 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 1,719 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018.
- F4Disposed of pursuant to merger agreement in exchange for 12,888 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
- F5This option was assumed by Quintiles in the merger and replaced with an option to purchase 30,720 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
- F6This option was assumed by Quintiles in the merger and replaced with an option to purchase 15,360 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
- F7This option was assumed by Quintiles in the merger and replaced with an option to purchase 30,720 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.
- F8This option was assumed by Quintiles in the merger and replaced with an option to purchase 1,920 shares of Quintiles IMS Holdings, Inc. common stock at a price of $25.53 per share.
- F9This option was assumed by Quintiles in the merger and replaced with an option to purchase 5,760 shares of Quintiles IMS Holdings, Inc. common stock at a price of $18.75 per share.
Remarks
Senior VP, General Counsel, External Affairs and Corporate Secretary